Search research articles
Contact Us
Filters
Showing results (71-80 of 133) with videos related to
Page
of 14
Sort By:
World Journal of Urology
|
March 24, 2019
Patients choose certainty over burden in bladder cancer surveillance
Frits H M van Osch, Duncan Nekeman, Neil K Aaronson, et al.
Frontiers in Oncology
|
March 15, 2021
PD-L2 Is Constitutively Expressed in Normal and Malignant Urothelium
Alexander C Dowell, Haydn Munford, Anshita Goel, et al.
European Urology Focus
|
July 21, 2017
A Comparative Analysis of the Influence of Gender, Pathway Delays, and Risk Factor Exposures on the Long-term Outcomes of Bladder Cancer
Richard T Bryan, Tim Evans, Janet A Dunn, et al.
BJU International
|
September 16, 2009
The West Midlands Bladder Cancer Prognosis Programme: rationale and design
Maurice P Zeegers, Richard T Bryan, Carolyn Langford, et al.
Proteomes
|
March 2, 2017
Use of <i>Aleuria alantia</i> Lectin Affinity Chromatography to Enrich Candidate Biomarkers from the Urine of Patients with Bladder Cancer
Sarah R Ambrose, Naheema S Gordon, James C Goldsmith, et al.
International Journal of Cancer
|
January 8, 2013
Smoking is associated with lower age, higher grade, higher stage, and larger size of malignant bladder tumors at diagnosis
Eline H van Roekel, Kar K Cheng, Nicholas D James, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
January 17, 2020
<i>MRE11A</i> Isoform Expression Associated with Outcome Following Radiotherapy in Muscle-Invasive Bladder Cancer does not Alter Cell Survival and DNA Double-Strand Break Repair Following Ionising Radiation
Alexandra K Walker, Juri Na, Lisa Browning, et al.
Biomarkers in Cancer
|
January 19, 2018
HumanMethylation450K Array-Identified Biomarkers Predict Tumour Recurrence/Progression at Initial Diagnosis of High-risk Non-muscle Invasive Bladder Cancer
Mark O Kitchen, Richard T Bryan, Richard D Emes, et al.
European Urology Open Science
|
May 2, 2022
STAG2 Protein Expression in Non-muscle-invasive Bladder Cancer: Associations with Sex, Genomic and Transcriptomic Changes, and Clinical Outcomes
Naheema S Gordon, Nada Humayun-Zakaria, Anshita Goel, et al.
BMC Cancer
|
June 30, 2023
Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer
Iliana K Kerzeli, Alexandros Kostakis, Polat Türker, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 133) with videos related to
Sort By:
Page
of 14
World Journal of Urology
|
March 24, 2019
Patients choose certainty over burden in bladder cancer surveillance
Frits H M van Osch, Duncan Nekeman, Neil K Aaronson, et al.
Frontiers in Oncology
|
March 15, 2021
PD-L2 Is Constitutively Expressed in Normal and Malignant Urothelium
Alexander C Dowell, Haydn Munford, Anshita Goel, et al.
European Urology Focus
|
July 21, 2017
A Comparative Analysis of the Influence of Gender, Pathway Delays, and Risk Factor Exposures on the Long-term Outcomes of Bladder Cancer
Richard T Bryan, Tim Evans, Janet A Dunn, et al.
BJU International
|
September 16, 2009
The West Midlands Bladder Cancer Prognosis Programme: rationale and design
Maurice P Zeegers, Richard T Bryan, Carolyn Langford, et al.
Proteomes
|
March 2, 2017
Use of <i>Aleuria alantia</i> Lectin Affinity Chromatography to Enrich Candidate Biomarkers from the Urine of Patients with Bladder Cancer
Sarah R Ambrose, Naheema S Gordon, James C Goldsmith, et al.
International Journal of Cancer
|
January 8, 2013
Smoking is associated with lower age, higher grade, higher stage, and larger size of malignant bladder tumors at diagnosis
Eline H van Roekel, Kar K Cheng, Nicholas D James, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
January 17, 2020
<i>MRE11A</i> Isoform Expression Associated with Outcome Following Radiotherapy in Muscle-Invasive Bladder Cancer does not Alter Cell Survival and DNA Double-Strand Break Repair Following Ionising Radiation
Alexandra K Walker, Juri Na, Lisa Browning, et al.
Biomarkers in Cancer
|
January 19, 2018
HumanMethylation450K Array-Identified Biomarkers Predict Tumour Recurrence/Progression at Initial Diagnosis of High-risk Non-muscle Invasive Bladder Cancer
Mark O Kitchen, Richard T Bryan, Richard D Emes, et al.
European Urology Open Science
|
May 2, 2022
STAG2 Protein Expression in Non-muscle-invasive Bladder Cancer: Associations with Sex, Genomic and Transcriptomic Changes, and Clinical Outcomes
Naheema S Gordon, Nada Humayun-Zakaria, Anshita Goel, et al.
BMC Cancer
|
June 30, 2023
Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer
Iliana K Kerzeli, Alexandros Kostakis, Polat Türker, et al.
Page
of 14